ALHC

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

New York, New York--(Newsfile Corp. - July 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

LOS ANGELES--(BUSINESS WIRE)--Whistleblower suit alleges Alignment misclassified $8-10M as capex to inflate EBITDA. Stock fell 16.7% to $20.03 on 7/8/26 news.

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

BENSALEM, Pa.--(BUSINESS WIRE)--Whistleblower suit alleges Alignment misclassified $8-10M as capex to inflate EBITDA. Stock fell 16.7% to $20.03 on 7/8/26 news.

SAN FRANCISCO, July 28, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. (NASDAQ: ALHC) following reports of a whistleblower lawsuit alleging systemic financial manipulation. SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSS Visit: www.hbsslaw.com/investor-fraud/alhc Contact the Firm Now: ALHC@hbsslaw.com                                           844-916-0895 Alignment Healthcare, Inc. (ALHC) Investigation: On July 8, 2026, news broke that a former Alignment Healthcare executive had filed a lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.

New York, New York--(Newsfile Corp. - July 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.

ATLANTA, July 27, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) complied with federal securities laws. On July 7, 2026, a former executive of Alignment filed a lawsuit against the Company alleging he was retaliated against after “he discovered and internally reported that the Company had materially misclassified, and continued to misclassify, millions of dollars in operating expenses (“OpEx”) as capital expenditures (“CapEx”).

LOS ANGELES--(BUSINESS WIRE)---- $ALHC--ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm.